SUBMIT IMAGE: The logo design of Sanofi is seen at the business’s head office in Paris, France, April 24,2020 REUTERS/Charles Platiau
PARIS (Reuters) – Sanofi has temporarily stopped recruiting brand-new COVID-19 clients for 2 medical trials on hydroxychloroquine and will no longer supply the anti-malaria drug to treat COVID-19 up until issues about safety are cleared up, it stated on Friday.
The relocations come after the World Health Organization paused its big trial of hydroxychloroquine, triggering numerous European governm